Hashimoto's Thyroiditis
The Autoimmune Driver Behind Most Hypothyroidism, and What That Changes

The primary markers are elevated anti-TPO and anti-thyroglobulin antibodies on a blood test. These can be elevated years before TSH becomes abnormal, which is why TSH-only screening misses Hashimoto's in early stages. Thyroid ultrasound can show the characteristic heterogeneous (uneven) echogenicity of Hashimoto's, with a coarsened texture and sometimes a mildly reduced gland volume. The antibody test is the key diagnostic step; ultrasound is supportive. When someone has symptoms consistent with hypothyroidism but a normal TSH, ordering antibodies is the logical next step.

Yes, and this is one of the most commonly missed clinical scenarios. In the early stages of Hashimoto's, thyroid tissue is being actively damaged by the immune response, but the gland still has enough reserve capacity to maintain adequate hormone output. TSH may be normal. But the inflammation itself, the direct effect of immune attack on thyroid tissue, can cause symptoms: fatigue, brain fog, fluctuating energy, mood changes, and sometimes transient hyperthyroid episodes (Hashitoxicosis) when damaged cells release stored hormone. These symptoms are real and have an identifiable cause; they're just not captured by TSH.

Not necessarily, and not on any fixed timeline. The rate of progression in Hashimoto's varies enormously between individuals. Some people have elevated antibodies for decades without significant change in TSH. Others progress to overt hypothyroidism within a few years. Factors that influence progression include antibody levels (higher is generally more aggressive), the degree of ultrasound change, selenium status (selenium deficiency accelerates the process), vitamin D levels, and whether other autoimmune conditions are present. Monitoring TSH and antibodies annually is reasonable. Treating the immune component may slow progression; waiting passively for hypothyroidism to develop before intervening is a missed opportunity.

Yes, and this matters clinically. Autoimmune conditions tend to cluster. Having Hashimoto's increases the risk of other autoimmune diseases including rheumatoid arthritis, type 1 diabetes, coeliac disease, lupus, and pernicious anaemia (autoimmune B12 deficiency). Coeliac disease is particularly relevant: there's a documented association between Hashimoto's and gluten-related immune activation. In some Hashimoto's patients, a strict gluten-free diet reduces anti-TPO antibody levels. This doesn't mean everyone with Hashimoto's needs to go gluten-free, but testing for coeliac disease antibodies (anti-tTG) is reasonable, and a dietary trial is low-risk and potentially high-value.

Several. Iodine excess: high iodine intake can increase antibody activity and worsen the autoimmune attack in genetically predisposed individuals. Selenium deficiency: selenium is required by the thyroid peroxidase enzyme and for antioxidant defence in thyroid cells; deficiency accelerates immune damage. Vitamin D deficiency: vitamin D has immunomodulatory effects and deficiency is associated with higher antibody levels. Chronic stress: elevated cortisol suppresses regulatory immune function, allowing autoimmune activity to proceed less checked. Gut dysbiosis and intestinal permeability: an emerging area suggesting that gut immune priming influences systemic autoimmunity. Correcting these factors doesn't cure Hashimoto's but can meaningfully reduce antibody burden and slow progression.

Hashitoxicosis is a transient hyperthyroid episode that can occur in Hashimoto's disease. When immune attack destroys thyroid follicles, stored thyroid hormone is released into the bloodstream in a burst. This temporarily raises T3 and T4, suppressing TSH and producing hyperthyroid symptoms: palpitations, anxiety, insomnia, tremor, and heat intolerance. The episode is usually short-lived (days to a few weeks) and self-limiting because the hormone release is finite, not from ongoing overproduction. It can be alarming and is often misidentified as Graves' disease. The clue is that TSH receptor antibodies (TRAb) are negative in Hashitoxicosis but positive in Graves'.